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Abstract
Objectives—To determine the association of Bacterial vaginosis (BV) and other sexually 
transmissible infections (STIs) with HIV prevalence among pregnant women in Jos, Nigeria.
Methods—This was a cross- sectional study of pregnant women who participated in the 
Prevention of Mother-to-Child Transmission of HIV program of the AIDS Prevention Initiative in 
Nigeria, between April 2002 and July 2004, at the Jos University Teaching Hospital in Jos, 
Nigeria. Blood, high vaginal and endocervical samples were obtained for diagnosis of HIV, BV 
and other STIs. Data were analyzed for prevalence of HIV, BV and other STIs. Univariate and 
multivariate logistic regression models generated unadjusted and adjusted odds ratios (OR) as well 
as 95% confidence intervals (CI) of the association of BV and other STIs with HIV prevalence. P 
value <0.05 was considered statistically significant.
Results—A total of 4,046 pregnant women were studied and 97.6% (3,950/4,046) had complete 
laboratory records for analysis. The prevalence of HIV was 8.2% (CI: 7.4–9.1); BV 11.9% (CI: 
10.9–12.9); Candida 10.7% (CI: 9.7–11.7); mixed infection of BV and Candida 2.8% (CI: 2.3–
3.4); Trichomonads 0.6% (CI: 0.3–0.8) and syphilis 0.35% (0.16–0.54). BV, Candida, mixed BV 
and Candida; and Trichomonads were independently associated with HIV infection [adjusted OR 
(95% CI), 2.9 (CI: 2.2–3.9); 2.0 (CI: 1.5–2.9); 3.4 (CI: 2.0–5.6), and 3.3 (CI: 1.1–9.7) 
respectively].
Conclusion—HIV prevalence is higher among pregnant women who have BV, Candida and 
Trichomonads vaginal infections compared with women who have no evidence of infection. The 
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practice of routine screening for BV and other STIs among pregnant women as a strategy for 
identifying women at risk for prevalent HIV infection should be sustained/ encouraged and the 
syndromic management of STIs should be integrated into all antenatal care management protocols 
in antenatal clinics in order to curb the epidemic of heterosexual HIV transmission.
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Introduction
Bacterial vaginosis (BV) is a non-inflammatory polymicrobial syndrome characterized by a 
depletion of Lactobacillus spp and an overgrowth of diverse aerobic, anaerobic and micro-
aerophilic species [1]. An estimated 25–30% of women have bacterial vaginosis at any 
given time, mostly without signs such as fishy odour or discharge [2]. The prevalence of BV 
is 85% among female sex workers’ (FSWs) populations [3], and is 17.5% and 29% among 
antenatal populations in Nigeria and Malawi respectively [4, 5].
BV has been strongly associated with adverse obstetric sequalae such as late miscarriage, 
spontaneous preterm rupture of membranes, chorioamnionitis, preterm labor, prematurity 
and related neonatal complications [6, 7]. The acidic environment of the normal vaginal 
flora inhibits colonization by potentially pathogenic organisms where as an alkaline 
environment in the presence of BV facilitates the growth of sexually transmissible agents. 
The association of BV and HIV as well as the possible mechanisms for the increase 
transmission and acquisition of HIV in the presence of BV have been documented [5, 8, 9, 
10,11].
The socio-demographic risk factors for HIV infection among pregnant women in Nigeria 
have been reported [4] as part of the behavioral surveillance study of pregnant women 
participating in the Prevention of Mother-to-Child Transmission (PMTCT) of HIV project, 
Jos University Teaching Hospital (JUTH), Jos, Nigeria. This study examines the association 
between BV and related sexually transmitted infections (STIs) with HIV infection among 
pregnant women in Jos, Nigeria. The findings from this study will further strengthen the 
evidence for screening and treatment of STIs as a HIV prevention intervention in Nigeria.
Methods
This was a cross-sectional study of pregnant women who participated in the PMTCT 
program at the AIDS Prevention Initiative Nigeria (APIN), JUTH, Jos between April 2002 
and July 2004. Details of the setting, study population and laboratory methods have been 
described [4]. In brief, the study procedure was as follows:
Those who consented to participate were recruited by a trained nurse counsellor who 
administered pre-test counselling one on one with each participant and obtained relevant 
socio-demographic variables using the Behavioral Surveillance Study questionnaire [4]. 
Afterwards, the participants were seen by a laboratory scientist for blood sample collection 
for HIV and VDRL tests. High Vaginal Swabs (HVS) and Endocervical Swabs (ECS) 
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Samples were collected for the diagnosis of trichomoniasis, candidiasis, bacterial vaginosis, 
and gonorrhoea.
The venous blood sample was tested for HIV and syphilis. The serum was screened for 
HIV-1 and HIV-2 using the Abbott Determine test kits (Abbott laboratories, Abbott park, IL 
USA). Western blot test was done in all cases of a positive rapid HIV test to confirm HIV 
infection based on the APIN approved protocol for diagnosis of HIV infection. Syphilis was 
diagnosed if the patient’s serum was reactive with both the Rapid Plasma Reagin Syfacard-R 
(Murex Biotech, Kent, UK) and the Determine Syphilis Treponema Pallidum Antibody 
Assay (Abbott, Wiesbaden, Germany).
For the diagnosis of other STIs, a wet mount of the vaginal swab was prepared in saline 
immediately after collection and examined microscopically for the presence of clue cells and 
motile trichomonas vaginalis. Direct microscopy of Gram-stained genital swabs was carried 
out for the detection of leukocytes and Gram-negative diplococci. Isolation of Neisseria 
gonorrhoea was done by inoculation of the endocervical swab on modified Thayer Martin 
media followed by incubation in a candle-extinctive jar at 36°C for 24–48 hours. Isolates 
were identified on the bases of colony morphology, visualization of Gram-negative 
diplococci, positive oxidase reaction and sugar fermentation tests. Antibiotic sensitivity was 
assessed on all N. gonorrhoea isolates to determine the appropriate drug of choice for 
treatment. Bacterial vaginosis was diagnosed according to the Amsel criteria [12].
Post-test counselling was offered by the nurse counselor, treatment of various STIs were 
offered by the gynaecologist in the PMTCT team and those HIV infected were evaluated 
and given appropriate antiretroviral treatment within the APIN treatment facility in JUTH.
Data management
Relevant Data were collected on a study questionnaire (Behavioral Surveillance Study 
questionnaire). Participants identification number, age and various laboratory findings and 
diagnosis were entered into File Maker Pro version 8 and exported into an excel file 
(Microsoft 2003) for subsequent analysis. Those with incomplete records on the laboratory 
diagnosis of HIV, BV or other STIs as well as those with Western Blot ‘Indeterminate’ HIV 
status were excluded from the final analysis.
Statistical analysis
All Statistical analyses were done using STATA version 11, StataCorp, College Station, 
Texas 77845, USA. We computed summary statistics for relevant variables, including age of 
the participants. The prevalence of BV, various STIs and HIV in the study population was 
also computed as proportion of participants detected with each of these conditions. We then 
conducted univariate analysis to assess the associations between HIV prevalence with a 
number of potential predictors, including BV and other STIs and results summarized using 
unadjusted odds ratios and 95% confidence interval. Multivariate logistic regression analysis 
was then performed to determine independent predictors of HIV prevalence. We included 
BV and STIs in the list of potential predictors in this analysis. All variables which remained 
significant in the models (with P value <0.05) were retained in the final model. We assessed 
confounding of variables not significant in the model by entering them one at a time into the 
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final model and retained only those which changed the estimate of any of the predictors in 
the model by more than 10%, indicating that they were confounders. Model fit was assessed 
with Hosmer-Lemeshow goodness-of-fit test.
Participants’ protection
The ethical committee of JUTH reviewed and approved this study.
Results
During the study period, a total of 97.6% (3,950/4,046) pregnant women had complete 
laboratory records suitable for analysis. The mean age of women was 28.18 years ± 6.44 
(95% CI 27.98–28.38).
The HIV prevalence was 8.2% (325/3950) with 95% confidence interval (CI) was 7.4%–
9.1%. The prevalence of BV and various STIs were 11.9%, 10.7%, 0.58%, 2.8%, 0.17% and 
0.35% respectively for BV, Candida, Trichomonads, combined BV and Candida; combined 
Candida and Trichomonads and syphilis.
The HIV prevalence among women with no evidence of STIs was 6.0% (175/2893), 95% CI 
5.2%–6.9% compare to a combine prevalence of 14.2% (150/1057), 95% CI 12.1% –16.3% 
among women who had one or more STIs. This difference was statistically significant with 
P-value <0.001.
In univariate models, the odds ratio (OR) and 95% CI for the association of BV and other 
STIs with HIV prevalence were: 2.4 (CI 1.8–3.2) for BV, 1.54 (CI 1.1–2.1) for Candida, 2.4 
(CI 0.80–7.0) for Trichomonads, 2.5 (CI 1.5–4.1) for combined BV and Candida infection, 
1.7 (CI 0.2–15.5) for combined Candida and Trichomonads infection and 1.9 (CI 0.4–8.4) 
for syphilis infection.
The multivariate model showed a significant association of increased HIV prevalence with 
BV and other STIs. The global LR X2 was 67.7, p value <0.0001, Pseudo R2=0.030. The 
adjusted OR of the association of HIV prevalence and various STIs were as shown in Table 
2 (No evidence of infection as referent category).
Discussion
The HIV prevalence of 8.2% found in this study is similar to the earlier report by Sagay et al 
[4] on pregnant women in the same population. The present report focuses mainly on the 
association of BV and related STIs with HIV prevalence in the same population. The 
findings of this study suggest that BV and related STIs are associated with a higher 
prevalence of HIV infection among pregnant women in Jos, Nigeria.
Our data showed that the prevalence of BV and other STIs was 11.9% (BV), 10.7% 
(Candida), 0.6% (Trichomonads) and 0.35% (Syphilis); some had mixed pathogens. The 
univariate models showed a significant association of BV, Candida and mixed infection of 
BV and Candida with increased prevalence of HIV. This association was significant in the 
multivariate model in addition to a significant association observed for Trichomonads in the 
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presence of other STIs in the model. Screening for these potential STIs as well as syndromic 
management of STIs could possibly have a significant impact in HIV prevention in our 
antenatal settings. Indeed, a prospective cohort study in Africa [13] has demonstrated a 
higher hazard of female-to-male transmission of HIV-1 in women who have evidence of BV 
infection compare to those without BV in HIV-serodiscordant HIV relationships after 
controlling for other confounding factors such as male circumcision, pregnancy, plasma 
HIV-1 RNA levels and sexual behavior. Our findings thus support the need to actively 
screen to detect and treat women with BV as a strategy for preventing HIV transmission in 
setting where BV prevalence is relatively high.
In view of the cross-sectional methodology in this study, we cannot establish a causal 
relationship of BV and other STIs with HIV acquisition; however, a prospective study [5] 
has documented a temporal association and therefore strengthens the causal hypothesis. 
There are several mechanisms by which BV and STIs could increase risk of HIV acquisition 
and transmission. First, the presence of hydrogen peroxide-producing Lactobacilli in the 
vagina results in a more acidic environment, which is not only toxic to BV-associated flora 
but also to HIV [14,15]. Lower vaginal pH may block the production of CD4 lymphocytes 
whereas a higher, more alkaline pH associated with BV, may enhance HIV survival.
Second, the BV microorganisms, especially M. hominis, are able to increase the activity of a 
soluble HIV-inducing factor and, therefore, increase HIV-1 expression [16]. Genital tract 
infection with G. vaginalis, which is commonly isolated in BV, has been shown to stimulate 
HIV-1 production and increase the likelihood of sexual transmission [17]. Furthermore, 
studies have shown that HIV load in the genital tract correlates positively with BV and 
inversely with absence of BV [10]. The evidence available supports a causal relationship 
between BV and HIV and BV may be an independent risk factor or a cofactor for 
transmission of HIV infection.
Although previous studies have documented that syphilis and other ulcerative STIs are 
strongly associated with increased risk of HIV acquisition and transmission [5], our data 
showed a non-significant association (adj. OR=2.6, CI: 0.6–11.7). This may be explained by 
the relatively few cases of syphilis (0.35%) in the population of women studied thereby 
lacking sufficient statistical power to detect a significant association.
The relatively large sample size in this study may have added strength and validity to our 
findings. However, we acknowledge the following limitations of the study. First, a few of 
the records were either missing or incomplete and were excluded from the final analysis. 
Second, women with ‘indeterminate’ HIV status by Western Blot were excluded. This might 
have resulted in some differential misclassification thereby affecting our point estimates.
Within our study limits, our data supports the practice of routine screening for BV and other 
STIs among pregnant women in Jos, Nigeria as a strategy for identifying women at risk for 
prevalent HIV infection in this population. Additionally, syndromic management of STIs 
should be integrated into all antenatal care management protocols in our antenatal clinics in 
order to curb the epidemic of heterosexual HIV transmission in Nigeria.
Imade et al. Page 5
Afr J Med Med Sci. Author manuscript; available in PMC 2015 December 15.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Acknowledgements
We are grateful to all the pregnant women who participated in this study, and the research staff, particularly 
Rosemary Omoregie, Gloria Angyo and Angela Momoh who coordinated client counselling, consenting and testing 
of biological samples. The study was supported by the Bill and Melinda Gates Foundation through the Harvard 
APIN project in collaboration with Jos University Teaching Hospital, Jos, Nigeria. Jonah Musa was supported by 
the NU-AITRP (ID43TW007995-01A1) for training in clinical investigations. We acknowledged the Medical 
Education Partnership Initiative in Nigeria (MEPIN) project funded by Fogarty International Center, the Office of 
AIDS Research, and the National Human Genome Research Institute of the National Institute of Health, the Health 
Resources and Services Administration (HRSA) and the Office of the U.S. Global AIDS Coordinator under Award 
Number R24TW008878 for support in data analysis and manuscript writing training.
References
1. Rosenstein IJ, Morgan DJ, Sheehan M, Lamont RF, Taylor-Robinson D. Bacterial vaginosis in 
pregnancy: distribution of bacterial species in different gram-stain categories of the vaginal flora. J 
Med Microbiol. 1996; 45:120–126. [PubMed: 8683547] 
2. Hillebrand L, Harmanli OH, Whiteman V, Khandelwal M. Urinary tract infection in women with 
bacterial vaginosis. Am J Obstet Gynecol. 2002; 186:916–917. [PubMed: 12015512] 
3. Behets F, Andriamiadana J, Rasamilalao D. Sexually transmitted infections and associated socio 
demographic and behavioural factors in women seeking primary care suggest Madagascar’s 
vulnerability to rapid HIV spread. Trop Med int Health. 2001; 6:202–211. [PubMed: 11299037] 
4. Sagay AS, Kapiga SH, Imade GE, Sankale JL, Idoko J, Kanki P. HIV infection among pregnant 
women in Nigeria. Int J Gynecol Obstet. 2005; 90:61–67.
5. Taha TE, Hoover DR, Dallabetta GA, Kumwenda NI, Mtimavalye LAR, Yang LP, et al. Bacterial 
vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV. AIDS. 
1998; 12:1699–1706. [PubMed: 9764791] 
6. Andrews WW, Goldenberg RL, Hauth IC. Preterm labour: emerging role of genital tract infections. 
Infect Agents Dis. 1995; 4:196–211. [PubMed: 8665085] 
7. Hillier SL, Nugent RP, Eschenbach DA, Krohn MA, Gibbs RS, Martin DH, et al. Association 
between bacterial vaginosis and preterm delivery of a low birth weight infant. N Engl J Med. 1995; 
333:1737–1742. [PubMed: 7491137] 
8. Taha T, Gray R, Kumwenda N, Hoover D. HIV infection and disturbances of vaginal flora during 
pregnancy. J Acquir Defic Syndr Hum Retrovirol. 1999; 20:52–59.
9. Hashemi FB, Ghassemi M, Roebuck KA, Spear GT. Activation of human immunodeficiency virus 
type 1 expression by Gardnerella vaginalis. J Infect Dis. 2000; 179:924–930. [PubMed: 10068588] 
10. Sha BE, Zariffard MR, Wang QJ, Chen HY, Bremer J, Cohen MH. Female genital tract HIV load 
correlates inversely with Lactobacillus species but positively with Bacterial vaginosis and 
Mycoplasma hominis. J Infect Dis. 2005; 191:25–32. [PubMed: 15592999] 
11. Mirmonsef P, Krass L, Landay A, Spear GT. The Role of Bacterial Vaginosis and Trichomonas in 
HIV Transmission Across The Female Genital Tract. Curr HIV Res. 2012; 10:202–210. [PubMed: 
22384839] 
12. Amsel R, Totten PA, Spiegel CA, Chen KC, Eschenbach D, Holmes KK. Non-specific vaginitis: 
diagnostic criteria and microbial and epidemiological associations. Am J Med. 1983; 74:14–22. 
[PubMed: 6600371] 
13. Cohen CR, Lingappa JR, Baeten JM, Ngayo MO, Spiegel CA, Hong T, et al. Bacterial vaginosis 
associated with increased risk of Female-to-Male HIV-1 Transmission: A Prospective Cohort 
Analysis among African Couples. PLos Med. 2012; 9:e1001251. [PubMed: 22745608] 
14. Klebanoff SJ, Coombs RW. Viricidal effects of L. acidophilus on human immunodeficiency virus 
type-1: possible role in heterosexual transmission. J Exp Med. 1991; 174:289–292. [PubMed: 
1647436] 
15. Mitchel C, Balkus JE, Fredricks D, Liu C, McKernan-Mullin J, Frenkel LM, et al. Interaction 
Between Lactobacilli, Bacterial Vaginosis-Associated Bacteria, and HIV Type 1 RNA and DNA 
Genital Shedding in U.S. and Kenyan Women. AIDS Res Hum Retroviruses. 2013; 29:13–19. 
[PubMed: 23020644] 
Imade et al. Page 6
Afr J Med Med Sci. Author manuscript; available in PMC 2015 December 15.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
16. Al-Harthi L, Roebuck KA, Olinger GG. Bacterial vaginosis-associated microflora isolated from the 
female genital tract activates HIV-1expression. J Acquir Immune Defic Syndr Hum Retrovirol. 
1999; 21:194–202.
17. Hashemi FB, Ghassemi M, Roebuck KA, Spear GT. Activation of human immunodeficiency virus 
type 1 expression by Gardnerella vaginalis. J Infect Dis. 2000; 179:924–930. [PubMed: 10068588] 
Imade et al. Page 7
Afr J Med Med Sci. Author manuscript; available in PMC 2015 December 15.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Imade et al. Page 8
Table 1
Baseline prevalence of HIV and STIs among Pregnant Women in Jos, Nigeria N=3,950
Outcome N Proportion (%) [95% confidence Interval]
HIV
  Negative 3,625 91.8 90.9–92.6
  Positive 325 8.2 7.4–9.1
STIs
  No evidence of infection 2,893 73.2 71.9–74.6
  BV 470 11.9 10.9–12.9
  Candida 423 10.7 9.7–11.7
  Trichomonads 23 0.6 0.3–0.8
  BV and Candida 112 2.8 2.3–3.4
  BV and Trichomonads 7 0.2 0.04–0.30
  BV, Cand and Tricho 1 0.0 0.00–0.00
  Candida and Tricho 7 0.2 0.04–0.30
  Syphilis 14 0.35 0.16–0.54
Cand= Candida, Tricho=Trichomonads, BV=Bacterial vaginosis
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Table 2
Multivariate logistic regression model of HIV prevalence with BV and other STIs among Pregnant Women in 
Jos, Nigeria.
HIV predictors adj. odds ratio [95% conf. Interval] P-value
BV 2.9 2.2–3.9 0.001
Candida 2.0 1.5–2.9 0.001
Trichomonads 3.3 1.1–9.7 0.033
BV and Candida 3.4 2.0–5.6 0.001
Candida and Tricho 2.6 0.3–21.7 0.378
Syphilis 2.6 0.6–11.7 0.214
Cand= Candida, Tricho=Trichomonads, BV=Bacterial vaginosis
*No evidence of infection as referent category
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